212 related articles for article (PubMed ID: 27625036)
1. Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease.
Cordaro M; Impellizzeri D; Gugliandolo E; Siracusa R; Crupi R; Esposito E; Cuzzocrea S
Mol Pharmacol; 2016 Nov; 90(5):549-561. PubMed ID: 27625036
[TBL] [Abstract][Full Text] [Related]
2. The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease.
Impellizzeri D; Bruschetta G; Di Paola R; Ahmad A; Campolo M; Cuzzocrea S; Esposito E; Navarra M
Clin Nutr; 2015 Dec; 34(6):1146-54. PubMed ID: 25491246
[TBL] [Abstract][Full Text] [Related]
3. Natural almond skin reduced oxidative stress and inflammation in an experimental model of inflammatory bowel disease.
Mandalari G; Bisignano C; Genovese T; Mazzon E; Wickham MS; Paterniti I; Cuzzocrea S
Int Immunopharmacol; 2011 Aug; 11(8):915-24. PubMed ID: 21354356
[TBL] [Abstract][Full Text] [Related]
4. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis.
Cuzzocrea S; Mazzon E; Serraino I; Lepore V; Terranova ML; Ciccolo A; Caputi AP
J Pineal Res; 2001 Jan; 30(1):1-12. PubMed ID: 11168901
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats.
Cuzzocrea S; Mazzon E; Serraino I; Dugo L; Centorrino T; Ciccolo A; Sautebin L; Caputi AP
Eur J Pharmacol; 2001 Nov; 431(1):91-102. PubMed ID: 11716847
[TBL] [Abstract][Full Text] [Related]
6. Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation.
Impellizzeri D; Di Paola R; Cordaro M; Gugliandolo E; Casili G; Morittu VM; Britti D; Esposito E; Cuzzocrea S
Biochem Pharmacol; 2016 Nov; 119():27-41. PubMed ID: 27599446
[TBL] [Abstract][Full Text] [Related]
7. The tyrosine kinase inhibitor tyrphostin AG 126 reduced the development of colitis in the rat.
Cuzzocrea S; McDonald MC; Mazzon E; Mota-Filipe H; Lepore V; Ciccolo A; Terranova ML; Britti D; Caputi AP; Thiemermann C
Lab Invest; 2000 Sep; 80(9):1439-53. PubMed ID: 11005212
[TBL] [Abstract][Full Text] [Related]
8. Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis.
Cuzzocrea S; McDonald MC; Mazzon E; Dugo L; Lepore V; Fonti MT; Ciccolo A; Terranova ML; Caputi AP; Thiemermann C
Eur J Pharmacol; 2000 Oct; 406(1):127-37. PubMed ID: 11011044
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide treatment reduces colon injury induced by experimental colitis.
Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
[TBL] [Abstract][Full Text] [Related]
10. Protective Effects of Ultramicronized Palmitoylethanolamide (PEA-um) in Myocardial Ischaemia and Reperfusion Injury in VIVO.
Di Paola R; Cordaro M; Crupi R; Siracusa R; Campolo M; Bruschetta G; Fusco R; Pugliatti P; Esposito E; Cuzzocrea S
Shock; 2016 Aug; 46(2):202-13. PubMed ID: 26844976
[TBL] [Abstract][Full Text] [Related]
11. Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis.
Di Paola R; Esposito E; Mazzon E; Riccardi L; Caminiti R; Dal Toso R; Pressi G; Cuzzocrea S
Biochem Pharmacol; 2009 Mar; 77(5):845-57. PubMed ID: 19070602
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin reduces the development of experimental inflammatory bowel disease.
Cuzzocrea S; Mazzon E; Di Paola R; Patel NS; Genovese T; Muià C; De Sarro A; Thiemermann C
J Pharmacol Exp Ther; 2004 Dec; 311(3):1272-80. PubMed ID: 15302898
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis.
Cuzzocrea S; Mazzon E; Dugo L; Caputi AP; Riley DP; Salvemini D
Eur J Pharmacol; 2001 Nov; 432(1):79-89. PubMed ID: 11734191
[TBL] [Abstract][Full Text] [Related]
14. Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat.
Cuzzocrea S; McDonald MC; Mazzon E; Mota-Filipe H; Centorrino T; Terranova ML; Ciccolo A; Britti D; Caputi AP; Thiemermann C
Gut; 2001 Apr; 48(4):478-88. PubMed ID: 11247891
[TBL] [Abstract][Full Text] [Related]
15. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
Esposito G; Capoccia E; Turco F; Palumbo I; Lu J; Steardo A; Cuomo R; Sarnelli G; Steardo L
Gut; 2014 Aug; 63(8):1300-12. PubMed ID: 24082036
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.
Borrelli F; Fasolino I; Romano B; Capasso R; Maiello F; Coppola D; Orlando P; Battista G; Pagano E; Di Marzo V; Izzo AA
Biochem Pharmacol; 2013 May; 85(9):1306-16. PubMed ID: 23415610
[TBL] [Abstract][Full Text] [Related]
17. The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats.
Impellizzeri D; Ahmad A; Bruschetta G; Di Paola R; Crupi R; Paterniti I; Esposito E; Cuzzocrea S
Eur J Pharmacol; 2015 Aug; 761():28-35. PubMed ID: 25934566
[TBL] [Abstract][Full Text] [Related]
18. Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: the relevance of cannabinoid system.
Matos I; Bento AF; Marcon R; Claudino RF; Calixto JB
Mol Immunol; 2013 Jul; 54(3-4):482-92. PubMed ID: 23454360
[TBL] [Abstract][Full Text] [Related]
19. Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice.
Di Paola R; Impellizzeri D; Mondello P; Velardi E; Aloisi C; Cappellani A; Esposito E; Cuzzocrea S
Shock; 2012 Oct; 38(4):356-66. PubMed ID: 22772472
[TBL] [Abstract][Full Text] [Related]
20. β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway.
Bento AF; Marcon R; Dutra RC; Claudino RF; Cola M; Leite DF; Calixto JB
Am J Pathol; 2011 Mar; 178(3):1153-66. PubMed ID: 21356367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
